Emergent BioSolutions | 现金及等价物



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 120.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


现金及等价物 更改 日
Acadia Pharmaceuticals USD 847.02M 85.02M 2025-09
Akebia Therapeutics USD 166.44M 29.14M 2025-09
ALKERMES USD 616.45M 95.25M 2025-09
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
ANI Pharmaceuticals USD 262.61M 44.81M 2025-09
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Coherus Biosciences USD 103.35M 113.54M 2025-09
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Exact Sciences USD 956M 166.96M 2025-12
Exelixis USD 482.49M 106.19M 2025-12
Glaxosmithkline GBP 3.3B 303M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
Lonza CHF 1.11B 286M 2024-12
Merck USD 18.17B 10.16B 2025-09
Moderna USD 2.6B 1.46B 2025-12
Myriad Genetics USD 145.4M 71M 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neurocrine Biosciences USD 713M 372.8M 2025-12
Pacira USD 147.59M 152.89M 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 672.62M 344.77M 2025-09
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
United Therapeutics USD 1.34B 253M 2025-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Xoma USD 143.9M 7.68M 2024-06


Emergent BioSolutions 现金及等价物 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.